Severe Adult-onset Still Disease with Constrictive Pericarditis and Pleuritis That Was Successfully Treated with Tocilizumab in Addition to Corticosteroids and Cyclosporin A
-
- Kawaguchi Hoshimi
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Tsuboi Hiroto
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Yagishita Mizuki
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Terasaki Toshihiko
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Terasaki Mayu
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Shimizu Masaru
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Honda Fumika
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Ohyama Ayako
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Takahashi Hiroyuki
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Miki Haruka
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Yokosawa Masahiro
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Asashima Hiromitsu
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Hagiwara Shinya
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Kondo Yuya
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Matsumoto Isao
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
-
- Sumida Takayuki
- Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
この論文をさがす
抄録
<p>Adult-onset Still disease (AOSD) is a systemic inflammatory disease characterized by fever, arthritis and rash. Corticosteroids represent a promising therapeutic option for AOSD; however, some resistant cases require immunosuppressants and biologic agents. We herein report the case of a 29-year-old Japanese man with severe AOSD, accompanied by constrictive pericarditis (CP) and pleuritis. Although 2 courses of steroid pulse and subsequent high-dose of prednisolone and cyclosporine A improved the patient's CP and pleuritis, his fever and inflammatory responses persisted. Tocilizumab (TCZ) was added to his treatment, which resulted in a rapid remission. This case suggests the usefulness of TCZ in the treatment of severe AOSD with CP and pleuritis. </p>
収録刊行物
-
- Internal Medicine
-
Internal Medicine 57 (7), 1033-1038, 2018
一般社団法人 日本内科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204875698048
-
- NII論文ID
- 130006602600
-
- NII書誌ID
- AA10827774
-
- ISSN
- 13497235
- 09182918
-
- HANDLE
- 2241/00151699
-
- PubMed
- 29269680
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可